Cardlytics Non Current Liabilities Total from 2010 to 2024
CDLX Stock | USD 9.24 0.50 5.13% |
Non Current Liabilities Total | First Reported 2016-12-31 | Previous Quarter 268.2 M | Current Value 267.3 M | Quarterly Volatility 106.2 M |
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 16.8 M, as well as many indicators such as Price To Sales Ratio of 1.03, Dividend Yield of 0.0 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
Cardlytics | Non Current Liabilities Total |
Latest Cardlytics' Non Current Liabilities Total Growth Pattern
Below is the plot of the Non Current Liabilities Total of Cardlytics over the last few years. It is Cardlytics' Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total | 10 Years Trend |
|
Non Current Liabilities Total |
Timeline |
Cardlytics Non Current Liabilities Total Regression Statistics
Arithmetic Mean | 185,484,441 | |
Geometric Mean | 140,637,783 | |
Coefficient Of Variation | 40.26 | |
Mean Deviation | 49,286,663 | |
Median | 177,188,000 | |
Standard Deviation | 74,675,584 | |
Sample Variance | 5576.4T | |
Range | 265.6M | |
R-Value | 0.16 | |
Mean Square Error | 5850.7T | |
R-Squared | 0.03 | |
Significance | 0.57 | |
Slope | 2,680,437 | |
Total Sum of Squares | 78070.2T |
Cardlytics Non Current Liabilities Total History
About Cardlytics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cardlytics income statement, its balance sheet, and the statement of cash flows. Cardlytics investors use historical funamental indicators, such as Cardlytics's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although Cardlytics investors may use each financial statement separately, they are all related. The changes in Cardlytics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cardlytics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cardlytics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Non Current Liabilities Total | 268.2 M | 206.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.